5 completed. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 5 |
Follow Antineoplastic Agents: new trials by email Literature Review of Antineoplastic Agents trials Research Report on Antineoplastic Agents
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hepatic Artery Infusion Chemotherapy Plus Donafenib in Patients With Hepatocellular Carcinoma After Surgery Hepatic arterial infusion chemotherapy, Folfox Protocol, Donafenib - Carcinoma, Carcinoma, Hepatocellular | Phase 2 | Completed | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 30 | 2021-12-27 | 2026-06-30 |
| TACE, Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCC TACE combined with sorafenib and PD-1 mAb - Hepatocellular Carcinoma, Liver Neoplasms | Phase 2 | Completed | Sichuan Cancer Hospital and Research Institute | 27 | 2020-09-14 | 2024-06-25 |
| Anlotinib in Metastatic HER2 Negative Breast Cancer Anlotinib Hydrochloride - Breast Neoplasm, Antineoplastic Agents | Phase 2 | Completed | Peng Yuan | 26 | 2018-07-12 | 2020-07-29 |
| Avelumab in Refractory Testicular Germ Cell Cancer. Avelumab - Testicular Neoplasms, Neoplasms, Germ Cell and Embryonal | Phase 2 | Completed | National Cancer Institute, Slovakia | 8 | 2017-11-15 | 2019-03-05 |
| Glivec in Prostate Cancer Patients With Rising PSA Following Radical Prostectomy STI571 (Glivec®) - Prostatic Neoplasm, Genital Neoplasms, Male | Phase 2 | Completed | Novartis Pharmaceuticals | 51 | 2003-06-01 | 2017-06-01 |
Carcinoma, Hepatocellular (2) · Digestive System Neoplasms (2) · Liver Neoplasms (2) · Abdominal Neoplasms (1) · Breast Neoplasms (1) · Carcinoma (1) · Genital Diseases, Male (1) · Genital Neoplasms, Male (1) · Gonadal Disorders (1) · Liver Diseases (1) · Neoplasms (1) · Neoplasms, Germ Cell and Embryonal (1) · Prostatic Diseases (1) · Prostatic Neoplasms (1) · Testicular Diseases (1)
Neoplasms by Site (5) · Neoplasms (4) · Neoplasms by Histologic Type (3) · Adenocarcinoma (2) · Digestive System Diseases (2) · Genital Diseases (2) · Male Urogenital Diseases (2) · Neoplasms, Glandular and Epithelial (2) · Urogenital Diseases (2) · Breast Diseases (1) · Carcinoma (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1)
Fluorouracil (1) · Folfox protocol (1) · Imatinib Mesylate (1) · Leucovorin (1) · Oxaliplatin (1) · Sorafenib (1) · anlotinib (1) · avelumab (1) · donafenib (1)
National Cancer Institute, Slovakia (1) · Novartis Pharmaceuticals (1) · Peng Yuan (1) · Sichuan Cancer Hospital and Research Institute (1) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (1)
China (3) · Germany (1) · Slovakia (1)
Lei Zhang, PHD (1) · Michal Mego, prof (1) · Peng Yuan (1)